ArticleJournal of neurology2022

Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion.

Massimo Filippi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.